Novasitol
Natural health product licensed in Canada
- Licence holder
- Nutramed Science Corporation
- NPN or DIN-HM
- 80085852
- Status
- Active licence
- Licence date
- 4 June 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Chrome: up to 200 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Myo-inositol Source : Inositol | 550 mg | Not calculated |
| D-Chiro-inositol Source : D-Chiro-inositol | 13.8 mg | Not calculated |
| Folate Source : Acide folique | 500 mcg | Not calculated |
| Vitamine E Source : d-alpha tocophérol | 25 UI | Not calculated |
| Vitamine D Source : Cholécalciférol | 500 UI | 25 µg |
| Chrome Source : Chlorure de chrome (III) | 100 mcg | 200 µg |
| Vitamine E Source : d-alpha tocophérol | 11.25 mg AT | Not calculated |
Non-medicinal ingredients
Dioxyde de titane, Cellulose microcristalline, Acide stéarique, Stéarate de magnésium, Croscarmellose de sodium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in the maintenance of good health. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s), a factor/factors in normal growth and development. Source of vitamin(s)/mineral(s)/vitamin(s) and mineral(s) to support biological functions which play a key role in the maintenance of good health. Multi-vitamin supplement or multi-mineral supplement or multi-vitamin and multi-mineral supplement. Helps to maintain the body's ability to metabolize nutrients. Helps to support normal early fetal development. Helps to support normal early development of the fetal brain and spinal cord. Helps to reduce the risk of neural tube defects when taken daily at least three months prior to becoming pregnant and during early pregnancy. Source of/An antioxidant that protects the fat in body tissues from oxidation. Helps in the absorption and use of calcium and phosphorus. Helps to build strong bones and teeth. Helps to maintain immune function. Helps in the process of normal cell division. Provides support for healthy glucose metabolism. Helps to maintain normal blood glucose levels. Helps to restore normal ovarian function in the management of polycystic ovarian syndrome (PCOS). Helps to restore ovulation, improve oocyte quality and to normalize menstrual cycle irregularities. Helps to manage hormonal and metabolic conditions in PCOS. Helps to decrease serum testosterone in women with PCOS. Helps to promote healthy glucose metabolism in the management of PCOS. Helps to promote pregnancy and fertility rate in PCOS women undergoing in vitro fertilization (IVF).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085852
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.